Diagnostic performance of upper airway sampling sites for SARS-CoV-2 and influenza testing
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.02212-25 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Mary Lopez-Perez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, Respiratory Tract Infections, SARS-CoV-2. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden.
Abstract (Originalsprache)
Early diagnosis of upper respiratory infections is essential to control infectious disease transmission within the community and to initiate relevant antiviral treatments. Nonetheless, variable sensitivities of sampling sites are often overlooked. We conducted a clinical trial at a COVID-19 outpatient test center, where healthcare workers collected nasopharyngeal, throat, nasal swabs, and saliva specimens. Each specimen was tested by RT-PCR for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus A and B, and respiratory syncytial virus (RSV). Clinical information was collected at enrollment and again 13 months later using an online questionnaire. From 4 March to 31 March 2023, 253 individuals were enrolled. Data from 250 participants were included in the analysis. SARS-CoV-2 was the most frequent viral infection (48%), followed by influenza A or B (5%), and a combination of SARS-CoV-2 and influenza (9%). RSV was not detected in any specimen. Several participants carried two or three viruses simultaneously. Throat swabs were significantly more sensitive for detecting SARS- CoV-2 (79%) and influenza (64%) than samples from other sites. In contrast, saliva had the lowest sensitivity for SARS- CoV-2 (43 % ) and was unsuitable for detecting influenza. The sensitivity for SARS- CoV-2 (88 % ) and influenza (100 % ) improved when results from throat and nasal swabs were combined. Throat swabs were more sensitive than nasopharyngeal swabs and saliva for molecular detection of SARS-CoV-2 and influenza. A combined throat and nasal swab is highly recommended to increase test sensitivity in patients presenting with upper respiratory infection symptoms. IMPORTANCE Upper respiratory infections are the most common condition in primary care. Therefore, their early diagnosis is essential to control infectious disease transmission within the community. Here, we show that throat swabs were more sensitive than nasopharyngeal swabs and saliva for detecting severe acute respiratory syndrome coronavirus 2. Furthermore, throat and nasal swabs were more effective in detecting influenza compared to nasopharyngeal swabs. CLINICAL TRIALS Registered at ClinicalTrials.gov NCT05765838 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Infectious Diseases, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark.
- Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
- Copenhagen Emergency Medical Services, University of Copenhagen, Copenhagen, Denmark.
- National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
ORCID-Profile: Mary Lopez-Perez, Tobias Todsen
Förderung
- Novo Nordisk Fonden
Zitieren
APA
Lopez-Perez, M., Benfield, T., Jakobsen, K. K., Dal, M. H., Stange, S. D., Ersbøll, A. K., Larsen, H., Berger, S. S., Gredal, T., Buchwald, C., Kirkby, N., & Todsen, T. (2026). Diagnostic performance of upper airway sampling sites for SARS-CoV-2 and influenza testing. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02212-25
Vancouver
Lopez-Perez M, Benfield T, Jakobsen KK, Dal MH, Stange SD, Ersbøll AK, et al. Diagnostic performance of upper airway sampling sites for SARS-CoV-2 and influenza testing. Microbiology Spectrum. 2026. doi:10.1128/spectrum.02212-25
BibTeX
@article{LopezPerez2026,
author = {Lopez-Perez, Mary and Benfield, Thomas and Jakobsen, Kathrine K and Dal, Mette Hyldig and Stange, Sabrina Dandanell and Ersbøll, Annette Kjær and Larsen, Helene and Berger, Sanne Schou and Gredal, Tobias and Buchwald, Christian von and Kirkby, Nikolai and Todsen, Tobias},
title = {Diagnostic performance of upper airway sampling sites for SARS-CoV-2 and influenza testing},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.02212-25}
}
EUVIMED